Collectively, these findings indicate a distinct immune landscape between the NXT1high and NXT1low groups, which indirectly supports the potential impact of NXT1 on the tumor immune microenvironment in HCC. This evidence concerns the gene NXT1 and hepatocellular carcinoma.